Bristol-Myers Squibb Company Ce
public_traded
Bristol-Myers Squibb Company Ce is publicly traded on NYSE under ticker CELG-RI.
Bristol Myers Squibb Co. engages in the discovery, development, licensing, manufacture, marketing, distribution, and sale of biopharmaceutical products. It offers small molecules, products produced from biological processes called biologics, and chimeric antigen receptor (CAR-T) cell therapies. The company was founded in August 1933 and is headquartered in Princeton, NJ.